ACP
Acuta Capital Partners Portfolio holdings
AUM
$71.6M
1-Year Return
169.78%
This Quarter Return
+36.4%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$225M
AUM Growth
+$46M
(+26%)
Cap. Flow
+$12.5M
Cap. Flow
% of AUM
5.58%
Top 10 Holdings %
Top 10 Hldgs %
63.98%
Holding
58
New
15
Increased
15
Reduced
5
Closed
10
Top Buys
| 1 |
BLU
BELLUS Health Inc.
BLU
|
$6.57M |
| 2 |
Sarepta Therapeutics
SRPT
|
$4.59M |
| 3 |
WHWK
Whitehawk Therapeutics, Inc. Common Stock
WHWK
|
$4.52M |
| 4 |
BioAtla
BCAB
|
$4M |
| 5 |
United Therapeutics
UTHR
|
$3.04M |
Top Sells
| 1 |
VistaGen Therapeutics
VTGN
|
$10M |
| 2 |
Arcus Biosciences
RCUS
|
$4.24M |
| 3 |
Orchestra BioMed
OBIO
|
$3.91M |
| 4 |
Precision BioSciences
DTIL
|
$3.28M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$1.98M |
Sector Composition
| 1 | Healthcare | 93.74% |
| 2 | Financials | 6.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Orchestra BioMed
OBIO
$148M
| – | – |
-392,500
| Closed | -$3.91M |
|
52
Ocular Therapeutix
OCUL
$2.37B
| – | – |
-13,171
| Closed | -$53K |
|
|
53
Arcus Biosciences
RCUS
$1.3B
| – | – |
-167,500
| Closed | -$4.24M |
|
54
Verastem
VSTM
$663M
| – | – |
-16,667
| Closed | -$232K |
|
|
55
VistaGen Therapeutics
VTGN
$109M
| – | – |
-378,715
| Closed | -$10M |
|